These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17162830)

  • 21. Overcoming the current approach in bipolar disorder research: towards DSM-V and beyond.
    Vieta E
    J Psychopharmacol; 2008 Jun; 22(4):406-7; discussion 408. PubMed ID: 18635719
    [No Abstract]   [Full Text] [Related]  

  • 22. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) for mood disorders: double-blind, placebo-controlled studies.
    Zhang ZJ; Kang WH; Li Q; Tan QR
    J Psychiatr Res; 2007 Nov; 41(10):828-36. PubMed ID: 17010995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.
    Möller HJ; Grunze H; Broich K
    Eur Arch Psychiatry Clin Neurosci; 2006 Feb; 256(1):1-16. PubMed ID: 16078087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of depressive mixed states].
    Dubois M; Dassa D; Belzeaux R; Fakra E; Cermolacce M; Corréard N; Kaladjian A; Azorin JM
    Encephale; 2013 Dec; 39 Suppl 3():S179-84. PubMed ID: 24359858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of rapid-cycling bipolar disorder.
    Post RM; Chang KD; Suppes T
    CNS Spectr; 2004 Feb; 9(2):1-11. PubMed ID: 15032235
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment pathways for bipolar disorder in the USA and Europe: convergence or divergence?
    Bowden C; Boyer P
    Eur Psychiatry; 2003 Dec; 18 Suppl 1():19s-24s. PubMed ID: 23573637
    [No Abstract]   [Full Text] [Related]  

  • 27. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maintaining mood stability in bipolar disorder: a clinical perspective on pharmacotherapy.
    Malhi GS; McAulay C; Das P; Fritz K
    Evid Based Ment Health; 2015 Feb; 18(1):1-6. PubMed ID: 25165167
    [No Abstract]   [Full Text] [Related]  

  • 30. On being bipolar without being bipolar.
    Goldberg J
    J Psychopharmacol; 2008 Jun; 22(4):402-3; discussion 408. PubMed ID: 18635717
    [No Abstract]   [Full Text] [Related]  

  • 31. Dysphoric mania, mixed states, and mania with mixed features specifier: are we mixing things up?
    McElroy SL; Keck PE
    CNS Spectr; 2017 Apr; 22(2):170-176. PubMed ID: 27866502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New anticonvulsant medication uses in bipolar disorder.
    Wang PW; Ketter TA; Becker OV; Nowakowska C
    CNS Spectr; 2003 Dec; 8(12):930-2, 941-7. PubMed ID: 14978468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decision tree for the treatment of bipolar disorder.
    Sachs GS
    J Clin Psychiatry; 2003; 64 Suppl 8():35-40. PubMed ID: 12892540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bipolar II disorder: current and future treatment options.
    El-Mallakh R; Weisler RH; Townsend MH; Ginsberg LD
    Ann Clin Psychiatry; 2006; 18(4):259-66. PubMed ID: 17162626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A different depression: clinical distinctions between bipolar and unipolar depression.
    Bowden CL
    J Affect Disord; 2005 Feb; 84(2-3):117-25. PubMed ID: 15708408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Weight gain in the treatment of mood disorders.
    Aronne LJ; Segal KR
    J Clin Psychiatry; 2003; 64 Suppl 8():22-9. PubMed ID: 12892538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study.
    McIntyre RS; Mancini DA; McCann S; Srinivasan J; Sagman D; Kennedy SH
    Bipolar Disord; 2002 Jun; 4(3):207-13. PubMed ID: 12180276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contemporary face of bipolar illness: complex diagnostic and therapeutic challenges.
    Fountoulakis KN
    CNS Spectr; 2008 Sep; 13(9):763-74, 777-9. PubMed ID: 18849896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study.
    Nolen WA; Kupka RW; Hellemann G; Frye MA; Altshuler LL; Leverich GS; Suppes T; Keck PE; McElroy S; Grunze H; Mintz J; Post RM
    Acta Psychiatr Scand; 2007 May; 115(5):360-5. PubMed ID: 17430413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.